These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25858577)

  • 1. Evaluation of abuse and dependence in addiction monitoring systems: tramadol as an example.
    Roussin A; Doazan-d'Ouince O; Géniaux H; Halberer C;
    Therapie; 2015; 70(2):203-21. PubMed ID: 25858577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse monitoring: which pharmacoepidemiological resources at the European level?
    Lapeyre-Mestre M; Dupui M
    Therapie; 2015; 70(2):147-65. PubMed ID: 25858571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.
    Dupui M; Micallef J; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P
    Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPPIDUM surveillance program: 20 years of information on drug abuse in France.
    Frauger E; Moracchini C; Le Boisselier R; Braunstein D; Thirion X; Micallef J;
    Fundam Clin Pharmacol; 2013 Dec; 27(6):672-82. PubMed ID: 23510229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal identification in addictovigilance: the functioning of the French system.
    Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A
    Therapie; 2015; 70(2):113-31. PubMed ID: 25858567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride).
    Woody GE; Senay EC; Geller A; Adams EH; Inciardi JA; Schnoll S; Muñoz A; Cicero TJ
    Drug Alcohol Depend; 2003 Nov; 72(2):163-8. PubMed ID: 14636971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France.
    Orriols L; Gaillard J; Lapeyre-Mestre M; Roussin A
    Drug Saf; 2009; 32(10):859-73. PubMed ID: 19722729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
    Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
    Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
    Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M;
    Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tramadol dependence: a survey of spontaneously reported cases in Sweden.
    Tjäderborn M; Jönsson AK; Ahlner J; Hägg S
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1192-8. PubMed ID: 19827010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.
    Adams EH; Breiner S; Cicero TJ; Geller A; Inciardi JA; Schnoll SH; Senay EC; Woody GE
    J Pain Symptom Manage; 2006 May; 31(5):465-76. PubMed ID: 16716877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal syndrome and dependence: tramadol too.
    Prescrire Int; 2003 Jun; 12(65):99-100. PubMed ID: 12825576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tramadol dependence with no history of substance abuse.
    Yates WR; Nguyen MH; Warnock JK
    Am J Psychiatry; 2001 Jun; 158(6):964. PubMed ID: 11384913
    [No Abstract]   [Full Text] [Related]  

  • 15. The investigation of tramadol dependence with no history of substance abuse: a cross-sectional survey of spontaneously reported cases in Guangzhou City, China.
    Zhang H; Liu Z
    Biomed Res Int; 2013; 2013():283425. PubMed ID: 24151592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe tramadol addiction in a 61 year-old woman without a history of substance abuse.
    Pollice R; Casacchia M; Bianchini V; Mazza M; Conti CM; Roncone R
    Int J Immunopathol Pharmacol; 2008; 21(2):475-6. PubMed ID: 18547496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Impairment and Tramadol Dependence.
    Bassiony MM; Youssef UM; Hassan MS; Salah El-Deen GM; El-Gohari H; Abdelghani M; Abdalla A; Ibrahim DH
    J Clin Psychopharmacol; 2017 Feb; 37(1):61-66. PubMed ID: 27918316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with tramadol can give rise to dependence and abuse].
    Näslund S; Dahlqvist R
    Lakartidningen; 2003 Feb; 100(9):712-4. PubMed ID: 12674559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abuse, dependence, or withdrawal associated with tramadol.
    Brinker A; Bonnel RA; Beitz J
    Am J Psychiatry; 2002 May; 159(5):881; author reply 881-2. PubMed ID: 11986164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.